References
- Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188–91.
- Hugues JN. Impact of ‘LH activity’ supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Hum Reprod 2012;27:232.
- Smitz J , Andersen AN , Devroey P , et al . Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod 2006;22:676–87.
- Hillier SG. Gonadotropic control of ovarian follicular growth and development. Molecular & Cellular Endocrinology 2001;179:39–46.
- Revelli A , Chiado’ A , Guidetti D , et al . Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study. J Assist Reprod Genet 2012;29:869–75.
- Diedrich K , Diedrich C , Santos E , et al . Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation. Hum Reprod 1994; 9:788–91.
- Balasch J , Vidal E , Peñarrubia J , et al . Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 2001;16:1636.
- Hill MJ , Levy G , Levens ED. Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature. Reprod Biomed Online 2012;24:261.
- Propst AM , Hill MJ , Bates GW , et al . Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration. Fertil Steril 2011;96:898–904.
- Kilani Z , Dakkak AS , Cognigni GE , et al . A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Hum Reprod 2003;18:1194.
- Andersen AN. Lack of association between endogenous LH and pregnancy in GnRH antagonist protocols. Reprod Biomed Online 2011;23:692–4.
- Doody KJ , Devroey P , Leader A , et al . No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. Reprod Biomed Online 2011;23:449.
- Baruffi RL , Mauri AL , Petersen CG , et al . Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reprod Biomed Online 2007;14:14–25.
- Griesinger G , Shapiro DB , Kolibianakis EM , et al . No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH. Reprod Biomed Online 2011;23:457–65.
- Chappel SC , Howles C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206–12.
- Humaidan P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update 2006;12:325.
- Listed N. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle. Hum Reprod 1998;13:3023–31.
- O'Dea L , O'Brien F , Currie K , Hemsey G. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect. Curr Med Res Opin 2008;24:2785.
- Marrs R , Meldrum D , Muasher S , et al . Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 2004;8:175–82.
- Humaidan P , Bungum M , Bungum L , Yding AC. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 2004;8:635.
- Mitchell R , Hollis S , Rothwell C , Robertson WR. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clin Endocrinol (Oxf) 1995;42:501–7.
- Vihko KK , Kujansuu E , Mörsky P , et al . Gonadotropins and gonadotropin receptors during the perimenopause. Eur J Endocrinol 1996;134:357–61.
- Hurwitz JM , Santoro N. Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med 2004;22:209–17.
- Kim YJ , Ku SY , Jee BC , et al . Effects of adding luteinizing hormone activity to gonadotropin releasing hormone antagonist protocols may differ according to age. Gynecol Endocrinol 2010;26:256–60.
- Weghofer A , Munné S , Brannath W , et al . The impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation embryos: antagonist cycles. Fertil Steril 2009;92:937–42.
- Hill MJ , Propst AM. The use of rLH, HMG and hCG in controlled ovarian stimulation for assisted reproductive technologies; 2012:54–76.
- Abramov Y , Elchalal U , Schenker JG. Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay?. Hum Reprod 1999;14:2930–1.
- Aboulghar M. Symposium: update on prediction and management of OHSS. Prevention of OHSS. Reprod Biomed Online 2009;19:7.